Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M, Osato M, Yamashita N, Liqun H, Jacob B, Wu F, Cao X, Nakamura T, Yokomizo T, Takahashi S, Yamamoto M, Shigesada K, Ito Y.
Yanagida M, et al. Among authors: nakamura t.
Oncogene. 2005 Jun 30;24(28):4477-85. doi: 10.1038/sj.onc.1208675.
Oncogene. 2005.
PMID: 15856017